Company
Corvus Pharmaceuticals
Power to Control the Immune System
Also known as Corvus Pharmaceuticals, Inc.
- Business model
- B2B
- Founded
- 2014
- Legal name
- Corvus Pharmaceuticals, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Corvus is a clinical-stage biopharmaceutical company developing novel therapies with the potential to significantly improve the treatment of immune diseases and cancer.
Funding snapshot
- Total raised
- $87.7MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $75M2015-09-16
Funding rounds
- Round, 2015
- $75M2015-09-16, SEC form D sold, 33 investors
- Round, 2014
- $12.7M2014-11-26, SEC form D sold, 12 investors
Loading relationship preview